Our campaigning priorities 2020-24 Date 28 September 2020 Sharing the results of the 'What Matters Most?' survey and coronavirus poll that have determined our campaigning priorities for the next four years
Our approach to starting in person activities Date 16 September 2020 Our in person events and activities have been on hold since March. We're taking a phased approach to starting them back up.
Trial results show statin drug does not slow Parkinson's Date 14 September 2020 Simvastatin is a drug already used to lower cholesterol, and prevent heart attacks and strokes. Initial results from a major clinical trial show it doesn't have potential to slow the progression of Parkinson's as previously hoped.
Research shows bad dreams could predict future memory and thinking problems Date 14 August 2020 Researchers in Portugal have discovered that the content of dreams, particularly those with negative emotions, may predict long-term cognitive decline in people with Parkinson’s.
Link found between diabetes and increased Parkinson’s risk Date 11 August 2020 An international team of researchers have uncovered a biological link that may account for why those with diabetes have a higher risk of developing Parkinson’s.
Parkinson’s UK commit further funding to develop drugs that protect mitochondria Date 4 August 2020 We’re investing a further £1 million to drive forward drugs that target energy-producing mitochondria to slow the loss of brain cells in Parkinson's.
Parkinson’s UK continues drug discovery with NRG Therapeutics Ltd. Date 3 August 2020 Parkinson's UK has invested an additional £1 million in NRG Therapeutics Ltd’s mitochondrial drug development programme.
How have coronavirus (COVID-19) restrictions impacted people affected by Parkinson’s? Date 2 July 2020 With Lancaster University, we conducted a survey that shows the coronavirus restrictions are having a big impact on the lives and the health of people affected by Parkinson’s.
Our response to Black Lives Matter Date 15 June 2020 Parkinson’s UK chose to stay quiet during the recent Black Lives Matter conversations. We believed that by giving others space to have their voices heard, we were playing a role in supporting their message. We were wrong.
Researchers identify key player in genetic Parkinson’s Date 29 April 2020 A team of researchers at the University of York have shown a protein called Rab10 plays an important role in the loss of brain cells in LRRK2-associated Parkinson’s.
